Human Bronchioalveolar Carcinoma Cell NCI-H358 Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 1.5 ml CRISPR(Cat-218042) | Inquiry | Add to cart | |
| 0.5 ml(Cat-686040) | Inquiry | Add to cart | |
| 1.5 ml(Cat-686141) | Inquiry | Add to cart | |
| 8.0 ml(Cat-706943) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 89% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
NCI-H358 is a type of lung cancer cell that comes from a specific kind of lung cancer called bronchioalveolar carcinoma. Scientists use this cell line to study lung cancer and develop new treatments. These cells can form gland-like structures in the lab, which is a feature of bronchioalveolar carcinoma. NCI-H358 cells have certain genetic changes that affect how they grow and divide. Researchers use these cells to study how lung cancer grows and spreads, how it becomes resistant to drugs, and how to develop new treatments. CD BioScience makes special kits that can be used to change the genetics of these cells.
